4//SEC Filing
Aunins John G. 4
Accession 0000899243-20-002210
CIK 0001609809other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:05 PM ET
Size
7.1 KB
Accession
0000899243-20-002210
Insider Transaction Report
Form 4
Aunins John G.
CTO and EVP of Bioprocess Dev.
Transactions
- Exercise/Conversion
COMMON STOCK
2020-01-26+12,500→ 105,250 total - Exercise/Conversion
RESTRICTED STOCK UNITS
2020-01-26−12,500→ 0 total→ Common Stock (12,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The restricted stock units are fully vested and do not have an expiration date.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001643756
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:05 PM ET
- Size
- 7.1 KB